Mainstream

Bioharvest outlines path to $11m–$12m quarterly revenue for adjusted ebitda breakeven while expanding vinia portfolio and cdmo pipeline

BioHarvest outlines path to $11M–$12M quarterly revenue for adjusted EBITDA breakeven while expanding VINIA portfolio and CDMO pipeline

BioHarvest outlines path to $11M–$12M quarterly revenue for adjusted EBITDA breakeven while expanding VINIA portfolio and CDMO pipeline

Post ContentbhstRead More

You might also be interested in reading FCA-Regulated Crypto Trading Firm Portofino Technologies Sees Staff Exodus.

May 16, 2025
In Mainstream